Importers of laboratory reagents and materials used in the manufacture of medicines in the UK’s life sciences sector have been given a six-month extension to make the necessary changes to their supply chains for new post-Brexit border paperwork and border inspections.

Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.